(Total Views: 444)
Posted On: 06/03/2020 11:08:05 AM
Post# of 154192
Re: Rex Eupseiphos #36386
Sure, processing EINDs take time and effort, but why's the FDA concerned about this? Are we to believe the FDA is so excited about leronlimab that they want the Company to only focus on getting enrollment finished?
NO! We know that the Company has made SEVERAL attempts to get get EUA based on "anecdotal" data from all the EINDs. The FDA is facetiously telling NP 'if you want the EUA so badly, stop coming to us with EIND results and finish your trials'.
The only way the FDA comes out looking good here is if EIND patients are taking away from potential trial participants. BUT this doesn't make any sense either because if this were the case, then the Company would easily have more than enough enrolled in their trials.
FUCK THE FDA!
NO! We know that the Company has made SEVERAL attempts to get get EUA based on "anecdotal" data from all the EINDs. The FDA is facetiously telling NP 'if you want the EUA so badly, stop coming to us with EIND results and finish your trials'.
The only way the FDA comes out looking good here is if EIND patients are taking away from potential trial participants. BUT this doesn't make any sense either because if this were the case, then the Company would easily have more than enough enrolled in their trials.
FUCK THE FDA!
(1)
(1)
